N@N

Whitney Ijem Maintained (BMRN) at Hold and Held Target at $89 on, Jul 25th, 2024

Whitney Ijem of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $89 on, Jul 25th, 2024.

Whitney has made no other calls on BMRN in the last 4 months.

There are 7 other peers that have a rating on BMRN. Out of the 7 peers that are also analyzing BMRN, 3 agree with Whitney's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024
• David Lebovitz of "Citigroup" Maintained at Hold with Decreased Target to $91 on, Thursday, April 25th, 2024
• George Farmer of "Scotiabank" Maintained at Hold with Increased Target to $85 on, Thursday, April 25th, 2024

These are the ratings of the 4 analyists that currently disagree with Whitney

---

• Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, July 22nd, 2024
• Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, June 27th, 2024
• Cory Kasimov of "Evercore ISI Group" Initiated at Buy and Held Target at $113 on, Tuesday, May 14th, 2024
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $112 on, Friday, April 26th, 2024

Contributing Sources

---